deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnosti... 29/04/2025 Healthcare Access to innovation Financing Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners Partners - Asabys Partners
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the ... 29/04/2025 Healthcare Innovative drugs Together, these studies reinforce the concept that advanced peptide-based brain shuttle technologies—central to the... Partners - Gate2Brain
Addressing Common Pitfalls in Clinical Study Protocols: Practical Solutions and Best Pract... Online Del 13/05/2025 17:00 to 13/05/2025 18:00 Healthcare
ICGT2025 - Innovation for Cell and Gene Therapies congress Gentilly France Del 22/05/2025 to 23/05/2025 Healthcare
15th Annual Outsourcing in Clinical Trials Europe 2025 Barcelona Spain Del 29/04/2025 to 30/04/2025 Healthcare
ORYZON continues to strengthen its patent portfolio for vafidemstat 22/04/2025 Healthcare Innovative drugs Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for ADHD and autism... Partners - Oryzon Genomics
Bio Equity Europe Bruges Belgium Del 12/05/2025 to 14/05/2025 Healthcare May 12–14, Bruges, Belgium May 20 - 21, virtual
ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadadem... 15/04/2025 Healthcare Innovative drugs Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the combination of its... Partners - Oryzon Genomics
CDMO LIVE Rotterdam Netherlands Del 07/05/2025 to 08/05/2025 Healthcare Access to innovation International
#NewAseBioMember | “AseBio is a key space for sharing experiences, generating synergies, a... 09/04/2025 Healthcare Corporate Meet our new member NoctuRNA. We spoke with a Miriam Corredor , CEO. AseBio - NOCTURNA THERAPEUTICS
